Ignite Creation Date:
2025-12-24 @ 12:48 PM
Ignite Modification Date:
2026-01-02 @ 3:11 PM
Study NCT ID:
NCT01021761
Status:
COMPLETED
Last Update Posted:
2011-08-31
First Post:
2009-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Sponsor:
Frank A. Bucci, Jr., M.D.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-25
First Submit QC Date:
None
Study First Post Date:
2009-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-25
Results First Submit QC Date:
None
Results First Post Date:
2011-08-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-08-26
Last Update Post Date:
2011-08-31
Last Update Post Date Type:
ESTIMATED